The Comments Are In On South African IP Framework; Action Seen In Early 2017 20/10/2016 by Linda Daniels for Intellectual Property Watch 1 Comment The invitation by the South African Department of Trade and Industry (DTI) to intellectual property stakeholders to comment on its recently released IP Consultative Framework has reignited calls for the department to come clean on the status of the national draft IP policy.
UNICEF Tender Allows Gavi To Supply Vaccines For Millions Of Children 20/10/2016 by Intellectual Property Watch 1 Comment Gavi, the vaccine alliance, announced yesterday that a UNICEF pentavalent vaccine tender will secure sufficient supplies for the next three years to protect millions of children in Gavi-supported and transitioning countries.
Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise 19/10/2016 by Tatum Anderson for Intellectual Property Watch Leave a Comment Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is interesting.
Nearly 100 Organisations Press For Better Medicines Access In Asian Region RCEP Agreement 19/10/2016 by William New, Intellectual Property Watch Leave a Comment Nearly 100 health, community and development organisations working in the Asia-Pacific region issued a call for trade ministers negotiating the Regional Comprehensive Economic Partnership (RCEP) trade agreement to “reject provisions that would negatively affect access to generic medicines.” Negotiators are meeting from 17-22 October in China, and the concern is about the intellectual property chapter of the deal.
Eli Lilly Commits To Healthcare For 30 Million People In Middle-Income Countries And US By 2030 18/10/2016 by Intellectual Property Watch Leave a Comment Pharmaceutical manufacturer Eli Lilly today announced a stepped-up commitment to provide improved access to quality healthcare for 30 million people in resource-limited settings by 2030.
WHO Pandemic Influenza Advisory Group Meeting In Secret This Week 18/10/2016 by Intellectual Property Watch 1 Comment The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.
55 Civil Society Groups Ask US Government To Allow Export Of Affordable Version Of Prostate Cancer Drug Xtandi 17/10/2016 by Intellectual Property Watch 1 Comment A range of 55 civil society organisations from around the world today sent a letter asking the United States Department of Health and Human Services to accept an offer from a Canadian generics company, Biolyse Pharma, to manufacture and export high-priced cancer drug Xtandi to countries with a per capita income of less than one-third that of the United States.
Paediatric Cancer Drug Being Developed Entirely In The Open 12/10/2016 by Tatum Anderson for Intellectual Property Watch 2 Comments The term “Open” in science is all the rage these days.
New MedsPaL Database: Enhancing Transparency In The Patent Field 07/10/2016 by Alexandra Nightingale for Intellectual Property Watch 1 Comment A new database was launched this week to facilitate navigation through the patent field and increase transparency surrounding the patent status of medicines and licences.
Fall Is A Time For Farewells, Hellos At UN Agencies, Law Offices, NGOs, Industry 06/10/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment As autumn rolled in, two United Nations agencies chose global figures to help them with their missions, another has a new website, and changed heads, while non-governmental organisations, law offices, and industry also saw numerous changes at management level.